4.1 Article

Telephone-adapted mindfulness-based stress reduction (tMBSR) for patients awaiting kidney transplantation: Trial design, rationale and feasibility

Journal

CONTEMPORARY CLINICAL TRIALS
Volume 42, Issue -, Pages 169-184

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cct.2015.03.013

Keywords

Mindfulness; MBSR; Telepsychology; Telemedicine; Kidney transplantation

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases Award [P01 DK013083]
  2. National Center for Advancing Translational Sciences Award [UL1TR000114]

Ask authors/readers for more resources

Background: Mindfulness-based stress reduction (MBSR) has demonstrated benefits for stress-related symptoms; however, for patients with burdensome treatment regimens, multiple comorbidities and mobility impairment, time and travel requirements pose barriers to MBSR training. Purpose: To describe the design, rationale and feasibility results of Journeys to Wellness, a clinical trial of mindfulness training delivered in a novel workshop and teleconference format The trial aim is to reduce symptoms and improve quality of life in people waiting for a kidney transplant. Methods: The standard 8-week MBSR program was reconfigured for delivery as two in-person workshops separated in time by six weekly teleconferences (tMBSR). A time and attention comparison condition (tSupport) was created using the workshop-telephone format. Feasibility results: Kidney transplant candidates (N = 63) were randomly assigned to tMBSR or tSupport: 87% (n = 55) attended >= class, and for these, attendance was high (6.6 +/- 1.8 tMBSR and 7.0 +/- 1.4 tSupport sessions). Fidelity monitoring found that all treatment elements were delivered as planned and few technical problems occurred. Patients in both groups reported high treatment satisfaction, but more tMBSR (83%) than tSupport (43%) participants expected their intervention to be quite a bit or extremely useful for managing their health. Symptoms and quality of life outcomes collected before (baseline, 8 weeks and 6 months) and after kidney transplantation (2, 6 and 12 months) will be analyzed for efficacy. Conclusions: tMBSR is an accessible intervention that may be useful to people with a wide spectrum of health conditions. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available